KBC Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56K | Sell |
1,774
-905
| -34% | -$28.6K | ﹤0.01% | 1557 |
|
|
2025
Q1 | $88K | Hold |
2,679
| – | – | ﹤0.01% | 1556 |
|
|
2024
Q4 | $97K | Buy |
2,679
+929
| +53% | +$33.6K | ﹤0.01% | 1582 |
|
|
2024
Q3 | $55K | Sell |
1,750
-25
| -1% | -$786 | ﹤0.01% | 1672 |
|
|
2024
Q2 | $47K | Hold |
1,775
| – | – | ﹤0.01% | 1657 |
|
|
2024
Q1 | $61K | Hold |
1,775
| – | – | ﹤0.01% | 1433 |
|
|
2023
Q4 | $51K | Hold |
1,775
| – | – | ﹤0.01% | 1514 |
|
|
2023
Q3 | $49K | Sell |
1,775
-2,373
| -57% | -$65.5K | ﹤0.01% | 1466 |
|
|
2023
Q2 | $125K | Sell |
4,148
-446
| -10% | -$13.4K | ﹤0.01% | 1104 |
|
|
2023
Q1 | $166K | Hold |
4,594
| – | – | ﹤0.01% | 1039 |
|
|
2022
Q4 | $164K | Hold |
4,594
| – | – | ﹤0.01% | 1035 |
|
|
2022
Q3 | $156K | Hold |
4,594
| – | – | ﹤0.01% | 1038 |
|
|
2022
Q2 | $133K | Buy |
+4,594
| New | +$133K | ﹤0.01% | 1118 |
|
|
2020
Q1 | – | Sell |
-13,592
| Closed | -$322K | – | 1433 |
|
|
2019
Q4 | $322K | Hold |
13,592
| – | – | ﹤0.01% | 1214 |
|
|
2019
Q3 | $374K | Sell |
13,592
-8,917
| -40% | -$245K | ﹤0.01% | 1153 |
|
|
2019
Q2 | $745K | Hold |
22,509
| – | – | 0.01% | 947 |
|
|
2019
Q1 | $789K | Buy |
+22,509
| New | +$789K | 0.01% | 932 |
|
|
2018
Q4 | – | Sell |
-9,306
| Closed | -$469K | – | 1372 |
|
|
2018
Q3 | $469K | Hold |
9,306
| – | – | ﹤0.01% | 1116 |
|
|
2018
Q2 | $557K | Sell |
9,306
-19,052
| -67% | -$1.14M | ﹤0.01% | 960 |
|
|
2018
Q1 | $1.3M | Hold |
28,358
| – | – | 0.01% | 695 |
|
|
2017
Q4 | $1.13M | Hold |
28,358
| – | – | 0.01% | 762 |
|
|
2017
Q3 | $1.13M | Hold |
28,358
| – | – | 0.01% | 774 |
|
|
2017
Q2 | $1.22M | Buy |
+28,358
| New | +$1.22M | 0.01% | 719 |
|